GB829246A - Improvements in or relating to new perfluoroalkyl-phenothiazine derivatives - Google Patents

Improvements in or relating to new perfluoroalkyl-phenothiazine derivatives

Info

Publication number
GB829246A
GB829246A GB32856/57A GB3285657A GB829246A GB 829246 A GB829246 A GB 829246A GB 32856/57 A GB32856/57 A GB 32856/57A GB 3285657 A GB3285657 A GB 3285657A GB 829246 A GB829246 A GB 829246A
Authority
GB
United Kingdom
Prior art keywords
carbon atoms
alkyl
trifluoromethylphenthiazine
piperazine
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB32856/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of GB829246A publication Critical patent/GB829246A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/24[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
    • C07D279/28[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom with other substituents attached to the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The invention comprises compounds of the general formula <FORM:0829246/IV (b)/1> and their non-toxic acid addition salts (wherein Y is a perfluoralkyl radical of 1 to 3 carbon atoms, A is an alkylene chain of from 2 to 6 carbon atoms separating the nitrogen atoms linked thereto by at least two carbon atoms, R1 is a hydrogen atom, R2, R3, R4 and R5 are hydrogen atoms or methyl or ethyl radicals, R6 is cycloalkyl with 5 or 6 carbon atoms, cycloalkylalkyl with 6 to 10 carbon atoms, alkenyl with 2 to 6 carbon atoms, dialkylamino-lower-alkyl with 1 to 6 carbon atoms in each of the alkyl portions and 2 to 6 carbon atoms in the lower-alkyl portion, hydroxy-lower-alkyl with 2 to 6 carbon atoms in the lower alkyl portion, hydroxy-lower-alkyl-oxy-lower-alkyl, the lower-alkyl portions having 2 to 6 carbon atoms, phenyl, cinnamyl, furoyloxybutyl, furoyl, thenyl, monocyclic aralkyl with 2 to 6 carbon atoms in the alkyl portion, aliphatic acyl with 1 to 6 carbon atoms, alicyclic aliphatic acyl with 7 to 10 carbon atoms, monocyclic aryl-aliphatic acyl with 6 to 10 carbon atoms, carbomethoxy, carbethoxy, carbobenzoxy, carbamyl, dialkyl carbamyl with 1 to 6 carbon atoms in the alkyl portions, N-phenyl carbamyl, aliphatic acyloxy-lower-alkyl with 1 to 6 carbon atoms in the acyloxy portion and 2 to 6 carbon atoms in the lower-alkyl portion, or monocyclic aroyloxy-lower-alkyl with 2 to 6 carbon atoms in the lower-alkyl portion). The compounds of the invention may be made by the following general reactions: (1) condense a 2-perfluoroalkyl phenthiazine with a reactive piperazinyl ester having the desired piperazinyl alkyl group; (2) react a piperazine with a 2-perfluoroalkylphenthiazine which is substituted in the 10-position by an alkyl chain with a reactive terminal group; (3) hydrolyse off R6 (when this is an easily-removable group like acyl) in the 2-perfluorophenthiazine derivative, and react the product so obtained with a reactive ester or ethylene oxide; (4) condense a 10-(o -amino-alkyl)-2-perfluoroalkylphenthiazine with a substituted bis-(b -haloalkyl)-amine. The general reactions (1) to (3) are illustrated in the examples. 1 - Formyl - 4 - (31 - chloropropyl) - piperazine is made by reacting thionyl chloride with 1-formyl-4-(31-hydroxypropyl)-piperazine, which is made from 1-(31-hydroxypropyl)-piperazine and methyl formate. 10 - (31 - Piperazinylpropyl) - 2 - trifluoromethylphenthiazine is made by treating 10-[31-(N - formylpiperazinyl) - propyl] - 2 - trifluoromethylphenthiazine in ethanol with sodium hydroxide. 2 - Trifluoromethylphenthiazine is reacted with ethylene oxide, and the b -hydroxyethyl compound obtained is reacted with thonyl chloride to give 10-(21-chloroethyl)-2-trifluomethylphenthiazine, treatment of which with piperazine yields 10-(2-piperazinylethyl)-2-trifluoromethylphenthiazine. N - carbethoxy - N1 - (g - chloro - b - methylpropyl)-piperazine is made from N-carbethoxypiperazine and 3-bromo-2-methylpropylchloride. 10 - [3 - (N - carbethoxy - piperazinyl) - 21 - methylpropyl] - 2 - trifluoromethylphenthiazine in ethanol is treated with sodium hydroxide to give 10 - (21 - methyl - 31 - piperazinylpropyl) - 2 - trifluoromethylphenthiazine. N - diethylcarbamyl - N1 - (g - chloropropyl) - piperazine is made from N-diethylcarbamylpiperazine and g -chloropropyl bromide. N - carbobenzoxy - 2,5 - diethylpiperazine is reacted with g -chloropropyl bromide to give 4 - carbobenzoxy - 1 - (o - chloropropyl) - 2,5 - diethylpiperazine, reaction of which with 2-trifluoromethyl-phenthiazine yields 10-[31-(N-carbobenzoxy - 211,511 - diethylpiperazinyl) - propyl] - 2-trifluorophenthiazine, treatment of which with sodium hydroxide gives 10-[31-(211,511-diethylpiperazinyl) - propyl] - 2 - trifluoromethylphenthiazine. 10 - [31 - (N - hydroxyethylpiperazinyl - propyl] - 2 - trifluoromethylphenthiazine is reacted with dichloroacetyl chloride, chloroacetyl chloride and chloroethyl chloroformate to give respectively 10 - [31 - (N - dichloroacetoxyethylpiperazinyl) - propyl] - 3 - trifluoromethylphenthiazine dihydrochloride, 10-[31-(N-chloroacetoxyethylpiperazinyl) - propyl] - 2 - trifluoromethylphenthiazine dihydrochloride and 10 - [31 - (N - chloroethoxycarbonyloxyethylpiperazinyl)-propyl]-2 - trifluoromethylphenthiazine dihydrochloride. Heptafluoropropylbenzene is nitrated by a mixture of nitric acid and concentrated sulphuric acid to give 1-heptafluoropropyl-3-nitrobenzene, reduction of which by hydrogen in the presence of Raney nickel gives 3-heptafluoropropylaniline, which on reacting with 2-chlorobenzoic acid yields 2 - (3 - heptafluoropropylphenylamino) - benzoic acid, decarboxylation of which gives 3-heptafluoropropyldiphenylamine, which on reacting with sulphur in the presence of iodine yields 2-heptafluoropropylphenthiazine.
GB32856/57A 1957-05-13 1957-10-21 Improvements in or relating to new perfluoroalkyl-phenothiazine derivatives Expired GB829246A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US658526A US3058979A (en) 1957-05-13 1957-05-13 New perfluoroalkylphenothiazine derivatives

Publications (1)

Publication Number Publication Date
GB829246A true GB829246A (en) 1960-03-02

Family

ID=24641614

Family Applications (1)

Application Number Title Priority Date Filing Date
GB32856/57A Expired GB829246A (en) 1957-05-13 1957-10-21 Improvements in or relating to new perfluoroalkyl-phenothiazine derivatives

Country Status (2)

Country Link
US (1) US3058979A (en)
GB (1) GB829246A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194733A (en) * 1961-04-26 1965-07-13 Olin Mathicson Chemical Corp Phenothiazine compositions and method of treating mental disorders
US7544681B2 (en) * 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
US8207369B2 (en) 2008-02-11 2012-06-26 Ramot At Tel-Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
US8222296B2 (en) 2006-07-17 2012-07-17 Ramot At Tel-Aviv University Ltd. Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders
WO2013138101A2 (en) 2012-03-16 2013-09-19 Children's Medical Center Corporation Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies
US8916610B2 (en) 2010-09-22 2014-12-23 Ramot At Tel-Aviv University Ltd. Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
US8975251B2 (en) 2009-12-09 2015-03-10 Bar-Ilan University Methods of improving cognitive functions
CN105153062A (en) * 2015-10-10 2015-12-16 江苏宝众宝达药业有限公司 Preparation method of permitil

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3394131A (en) * 1961-04-26 1968-07-23 Squibb & Sons Inc Acid esters of phenothiazine
US3152126A (en) * 1963-01-14 1964-10-06 Olin Mathieson New diesters of phenothiazines
US3282934A (en) * 1964-05-15 1966-11-01 Schering Corp Nitrogenous esters of hydroxylalkylamino phenothiazines
US3317537A (en) * 1965-06-25 1967-05-02 Colgate Palmolive Co Piperazinoalkyl-morphanthridines
US5114942A (en) * 1989-03-31 1992-05-19 Yale University Treating habit disorders
US5059600A (en) * 1989-03-31 1991-10-22 Yale University Treating habit disorders
US5223497A (en) * 1989-03-31 1993-06-29 Yale University Treating habit disorders
US6004980A (en) * 1990-06-01 1999-12-21 Merrell Pharmaceuticals, Inc. (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
DE69105501T2 (en) * 1990-06-01 1995-04-13 Merrell Dow Pharma (+) - ALPHA- (2,3 DIMETHOXYPHENYL) -1- [2- (FLUOROPHENYL) ETHYL] -4-PIPERIDINE METHANOL.
CZ114199A3 (en) * 1996-10-04 1999-09-15 Novo Nordisk A/S N-substituted azaheterocyclic compounds
US6028083A (en) * 1997-07-25 2000-02-22 Hoechst Marion Roussel, Inc. Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
CN1674879A (en) * 2002-06-17 2005-09-28 费城健康与教育公司 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
DE60307049T2 (en) * 2003-04-25 2007-02-08 Neuro3D Use of piperazine phenothiazine derivatives for the manufacture of a medicament having neuroprotective and / or neurotropic effects on the CNS and / or PNS
BRPI0610028A2 (en) * 2005-04-22 2010-05-18 Wyeth Corp therapeutic combinations for the treatment or prevention of psychotic disorders
CA2662215A1 (en) * 2006-09-01 2008-03-06 Immune Control, Inc. Novel compositions and methods for treatment of diseases related to activated lymphocytes
GB0701970D0 (en) * 2007-02-01 2007-03-14 Wilson Stuart Treatment of protein aggregation diseases
EP3574920A1 (en) * 2018-05-31 2019-12-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nupr1 inhibition for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE537689A (en) * 1954-04-27
NL108827C (en) * 1956-04-09
BE558008A (en) * 1956-06-21

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194733A (en) * 1961-04-26 1965-07-13 Olin Mathicson Chemical Corp Phenothiazine compositions and method of treating mental disorders
US8283381B2 (en) 2001-09-27 2012-10-09 Ramot At Tel-Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
US7598239B2 (en) * 2001-09-27 2009-10-06 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
US7619006B2 (en) * 2001-09-27 2009-11-17 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
US7939525B2 (en) 2001-09-27 2011-05-10 Bar-Ilan University Conjugated psychotropic drugs and uses thereof
US8168628B2 (en) 2001-09-27 2012-05-01 Ramot At Tel-Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
US7544681B2 (en) * 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
US8377990B2 (en) 2006-07-17 2013-02-19 Ramot At Tel-Aviv University Ltd. Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders
US8222296B2 (en) 2006-07-17 2012-07-17 Ramot At Tel-Aviv University Ltd. Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders
US8207369B2 (en) 2008-02-11 2012-06-26 Ramot At Tel-Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
US8722923B2 (en) 2008-02-11 2014-05-13 Ramot At Tel-Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
US8975251B2 (en) 2009-12-09 2015-03-10 Bar-Ilan University Methods of improving cognitive functions
US8916610B2 (en) 2010-09-22 2014-12-23 Ramot At Tel-Aviv University Ltd. Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
WO2013138101A2 (en) 2012-03-16 2013-09-19 Children's Medical Center Corporation Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomapathies
EP3461482A1 (en) 2012-03-16 2019-04-03 Children's Medical Center Corporation Calcium channel blockers for the treatment of ribosomal disorders and ribosomapathies
CN105153062A (en) * 2015-10-10 2015-12-16 江苏宝众宝达药业有限公司 Preparation method of permitil

Also Published As

Publication number Publication date
US3058979A (en) 1962-10-16

Similar Documents

Publication Publication Date Title
GB829246A (en) Improvements in or relating to new perfluoroalkyl-phenothiazine derivatives
US2750387A (en) Basically substituted derivatives of diarylaminobenzamides
US3621043A (en) N-substituted octadecadienoic acid amides as cholesterol lowering agents
US2948736A (en) New anilides and process for their production
GB1086191A (en) Phenylcyclopropane derivatives
ATE24904T1 (en) COMPOUNDS EFFECTIVE IN TREATMENT OF STOMACH ULCERS AND SKIN SENSITIVITY SYMPTOMS.
CH449632A (en) Process for the preparation of cyclic diazacycloalkane compounds
US2862965A (en) Pharmaceutical compounds
US2824102A (en) Aminoalkyl-2h, 1, 4-benzothiazin-3(4h)-ones
IE43375B1 (en) Substituted benzamides, their preparation, and compositions containing them
US2847419A (en) Propynyl dithiocarbamates
US3480663A (en) Terpene ester carbamic acids
US2997468A (en) Preparation of phenothiazines
US2683735A (en) Aromatic esters of basically substituted isocyclyl carbamates
US3624086A (en) Adamantanecarboxamidoalkanoic acid amides
US3223703A (en) 3-carbalkoxy- and 3-carbamoyl-5-subtituted - (2h) - 1,2,6 - thiadiazine - 1,1-dioxides and process
US3544587A (en) Substituted toluidides and compositions containing them
US3562267A (en) Derivatives of 3-(5-nitrofur-2-yl)-5-aminoisoxazoles
Kaye et al. Thiocyanation of p-Dialkylaminoalkoxyanilines
US2772288A (en) Basic esters of n-aryl and n-cycloalkyl indancarbamic acids, their salts and methods for their preparation
US3711538A (en) Delta 2,alpha-adamantaneacetanilide derivatives and related compounds
US2832775A (en) N - alkoxyalkyl - n - alkyl-
US2578053A (en) Piperazine oxides and method of
US3470173A (en) 1-chloro-cycloalkane-1-carbox amides
GB889223A (en) Phenylpiperazinylalkyl esters and amides